Citius Oncology (CTOR) Other Non-Current Liabilities (2024 - 2026)

Citius Oncology (CTOR) has 3 years of Other Non-Current Liabilities data on file, last reported at $559015.0 in Q1 2026.

• On a quarterly basis, Other Non-Current Liabilities changed 0.0% year-over-year to $559015.0 in Q1 2026; TTM through Mar 2026 was $559015.0, a 0.0% change from a year earlier, with the FY2025 full-year figure at $559015.0, changed N/A from the prior year.
• Other Non-Current Liabilities for Q1 2026 stood at $559015.0, roughly flat from $559015.0 in the prior quarter.
• Over the last five years, Other Non-Current Liabilities for CTOR reached as high as $559015.0 in Q4 2024 and fell as low as $559015.0 in Q4 2024.
• Historically, Other Non-Current Liabilities has averaged $559015.0 across 3 years, with a median of $559015.0 in 2024.
• On a YoY basis, Other Non-Current Liabilities climbed as much as 0.0% in 2025 and fell as far as 0.0% in 2025.
• Year by year, Other Non-Current Liabilities stood at $559015.0 in 2024, then changed by 0.0% to $559015.0 in 2025, then changed by 0.0% to $559015.0 in 2026.
• Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $559015.0 in Q1 2026, $559015.0 in Q4 2025, and $559015.0 in Q3 2025.